Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort Jul 18, 2019
Moleculin Files for New Patents for Annamycin After Receiving FDA Approval of Fast Track Designation Jul 10, 2019
Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2019 May 14, 2019
Moleculin Announces Additional Positive Interim Results in First Cohort of Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia in Europe May 7, 2019
US Biopharma Company Undertakes Anti-Cancer Clinical Trials in Poland, First Patient Showing Positive Initial Treatment Apr 29, 2019
Moleculin Announces Conference Call to Discuss Significant Discovery For Lung Cancer and FDA Activity on Wednesday, April 24, 2019 Apr 22, 2019
Moleculin Announces Agreement with Emory University to Conduct Pediatric Brain Tumor Trial Apr 11, 2019
